News

1 to 9 of 46 results

EMA/CHMP January meeting highlights

EMA/CHMP January meeting highlights

24-01-2014

There were a number of positive, and negative, opinions issued on January 24, following the monthly meeting…

AB ScienceAdempasBayerBemfolaDainippon Sumitomo PharmaEuropeFinox BiotechHemoprostolLatudaLinepharmaMasivieraNerventraNovartisPTC TherapeuticsReasanzRegulationTakeda PharmaceuticalsTeva Pharmaceutical IndustriesTranslarna

2014: A new dawn for pharma?

2014: A new dawn for pharma?

10-01-2014

We take a look at the week's top stories.

Asia-PacificManagementNovartisPharmaceuticalTeva Pharmaceutical IndustriesUK

US FDA approves Teva’s generic TOBI

US FDA approves Teva’s generic TOBI

14-10-2013

Teva Pharmaceutical Industries says that the US Food and Drug Administration has granted approval of…

Antibiotics and Infectious diseasesGenericsNovartisRare diseasesRegulationTeva Pharmaceutical IndustriesTobi

US Appeals Court overturns Copaxone patent decision

28-07-2013

Israel-based generics giant Teva Pharmaceutical Industries ((NYSE: TEVA) said on Friday (July 26) that…

CopaxoneGenericsLegalMomenta PharmaceuticalsMylan LaboratoriesNatco PharmaNeurologicalNorth AmericaNovartisPatentsPharmaceuticalSandozTeva Pharmaceutical Industries

ANN meeting highlights: Novartis' Gilenya, Lundbeck's Azilect, Orion's ODM-101, Biotie's tozadenant

21-03-2013

Among the highlights of the annual meeting of the American Academy of Neurology taking place in San Diego,…

AzilectBiotie TherapiesGilenyaLundbeckNeurologicalNovartisODM-101Orion CorpPharmaceuticalResearchTeva Pharmaceutical Industriestozadenant

FDA approves Teva's Synribo for CML; Novartis plans for Tasigna switch

29-10-2012

The US Food and Drug Administration on Friday approved Israel-headquartered Teva Pharmaceutical Industries'…

GleevecNorth AmericaNovartisOncologyPatentsPharmaceuticalRegulationResearchSynriboTasignaTeva Pharmaceutical Industries

Playing ball with Russia in the pharma sector

16-09-2012

Commenting on last week's announcement that Takeda Pharmaceuticals (TYO: 4502) had completed its $96…

EuropeNovartisPharmaceuticalPoliticsProductionTakeda PharmaceuticalsTeva Pharmaceutical Industries

1 to 9 of 46 results

COMPANY SPOTLIGHT

Menarini

Back to top